Form 4: Omnicell Director Bruce E. Scott Receives Stock Grant
SEC Form 4 Filing
Director Bruce E. Scott received 6,177 shares of Omnicell stock as part of the company's equity incentive plan.
Summary
- Bruce E. Scott, a director at Omnicell, Inc., received 6,177 shares of common stock on May 21, 2024.
- The shares were granted under the Issuer's equity incentive plan in consideration of services as a Board Member pursuant to the Issuer's Board of Directors Compensation Plan.
- The grant was priced at $0.
- Following the transaction, Scott directly owns 16,111 shares of Omnicell stock.
- The restricted shares will vest in full on the date of the Issuer's 2025 Annual Meeting of Stockholders.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. It reflects a standard compensation practice for a director, indicating confidence in the company's future.
Positives
- The grant of shares aligns the director's interests with those of the shareholders.
- The equity incentive plan is a common way to compensate board members.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting date of the restricted shares.
Industry Context
Stock grants to directors are a common practice in publicly traded companies to align their interests with shareholders and incentivize them to contribute to the company's long-term success.
Comparison to Industry Standards
- Director compensation packages, including stock grants, vary significantly across industries and company sizes.
- Comparing Omnicell's director compensation to that of its peers in the healthcare technology sector would provide a more comprehensive understanding of its competitiveness.
- Companies like Cerner (now Oracle Health), Allscripts, and McKesson also utilize equity-based compensation for their board members.
Stakeholder Impact
- The stock grant aligns the director's interests with those of the shareholders, potentially leading to better decision-making.
- The grant has a minimal impact on employees, customers, suppliers, and creditors.
Key Dates
| Date | Description |
|---|---|
| 05/21/2024 | Date of transaction: Grant of 6,177 shares of common stock. |
| 05/23/2024 | Date of signature on the Form 4 filing. |
| 2025 Annual Meeting of Stockholders | Vesting date for the restricted shares. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.